GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹549 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹502 Cr |
| Mar2024 | ₹405 Cr |
| Mar2023 | ₹517 Cr |
| Mar2022 | ₹413 Cr |
| Mar2021 | ₹549 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹502 Cr | 23.74 | |
| Mar2024 | ₹405 Cr | -21.54 | |
| Mar2023 | ₹517 Cr | 25.16 | |
| Mar2022 | ₹413 Cr | -24.88 | |
| Mar2021 | ₹549 Cr | - | |
Compare Consolidated Net Profit of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,240.1 Cr | 4% | 17.6% | 80.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 4% |
17.6% |
80.5% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses